Health & Life Sciences

Our seasoned team of policy advisers specialising in health and life sciences, sustainability, and retail and supply chains, help clients in these technology-enabled sectors drive and navigate policy change to deploy innovation that improves the health of people and the planet.

Product, Platform, and Disease-Specific Policy & Government Affairs: We navigate the complex landscape of policy and government affairs specific to individual products, platforms like AAV-based gene therapy and CAR-T, diseases like COPD and cervical cancer, and broader therapeutic areas from oncology to infectious disease. Our approach integrates deep political insights with a keen understanding of health and life sciences innovation to foster environments that enhance market entry and sustainability. Our expertise has been called upon for companies looking to influence laws, streamline product approvals, prepare for launch, and expand coverage. We focus on creating strategic, win-win engagements with policymakers and patients, ensuring that the interests of our clients are effectively represented and advanced.

Multistakeholder Alliances, Coalitions, and Public-Private Partnerships: Our team excels in orchestrating and leading multistakeholder alliances, coalitions, and public-private partnerships that drive forward health and life sciences policy priorities. By leveraging our extensive network across government, industry, academia, and civil society, we create synergistic collaborations that accelerate innovation and access to healthcare solutions. These partnerships can stand alone as independent initiatives or become embedded within or adjacent to multilateral forums like APEC and Summit of the Americas. They are tailored to harness collective strengths, address common challenges, and optimize outcomes in healthcare delivery and disease management, particularly in areas like rare diseases and immunization.

Market Shaping and Market Access Strategy: We are a leader in developing market shaping and access strategies that ensure the successful launch and sustained availability, accessibility, and affordability of medical innovations. Our strategic insights help clients navigate complex pricing, reimbursement, and access landscapes from a proactive, upstream, and government affairs/policy-oriented perspective. By analyzing market trends and stakeholder needs, we work with our Market Access teams to design and implement strategies that optimize product positioning, help educate payer bodies and HTA bodies, and maximize patient reach.